These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27171002)
1. MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression. Egaña-Gorroño L; Guardo AC; Bargalló ME; Planet E; Vilaplana E; Escribà T; Pérez I; Gatell JM; García F; Arnedo M; Plana M M; PLoS One; 2016; 11(5):e0155245. PubMed ID: 27171002 [TBL] [Abstract][Full Text] [Related]
2. Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors. Egaña-Gorroño L; Escribà T; Boulanger N; Guardo AC; León A; Bargalló ME; Garcia F; Gatell JM; Plana M; Arnedo M; PLoS One; 2014; 9(9):e106360. PubMed ID: 25225963 [TBL] [Abstract][Full Text] [Related]
3. Utility of Systematic Isolation of immune cell subsets from HIV-infected individuals for miRNA profiling. Bargalló ME; Guardo AC; Maleno MJ; Miralles L; Egaña-Gorroño L; Escribà T; García F; Gatell JM; Arnedo M; Plana M J Immunol Methods; 2017 Mar; 442():12-19. PubMed ID: 28039100 [TBL] [Abstract][Full Text] [Related]
4. Elevated Expression of miR-19b Enhances CD8 Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN Front Immunol; 2018; 9():3140. PubMed ID: 30687333 [TBL] [Abstract][Full Text] [Related]
5. T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness. Downey JS; Attaf M; Moyle G; Gazzard B; Gotch F; Imami N AIDS; 2011 Oct; 25(16):1981-6. PubMed ID: 21811141 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts. Duskova K; Nagilla P; Le HS; Iyer P; Thalamuthu A; Martinson J; Bar-Joseph Z; Buchanan W; Rinaldo C; Ayyavoo V BMC Infect Dis; 2013 May; 13():250. PubMed ID: 23721325 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-210, MicroRNA-331, and MicroRNA-7 Are Differentially Regulated in Treated HIV-1-Infected Individuals and Are Associated With Markers of Systemic Inflammation. Ballegaard V; Ralfkiaer U; Pedersen KK; Hove M; Koplev S; Brændstrup P; Ryder LP; Madsen HO; Gerstoft J; Grønbæk K; Nielsen SD J Acquir Immune Defic Syndr; 2017 Apr; 74(4):e104-e113. PubMed ID: 27749601 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional insights into the CD8 Li SY; Zhang ZN; Jiang YJ; Fu YJ; Shang H J Transl Med; 2020 Feb; 18(1):96. PubMed ID: 32093694 [TBL] [Abstract][Full Text] [Related]
9. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Witwer KW; Watson AK; Blankson JN; Clements JE Retrovirology; 2012 Jan; 9():5. PubMed ID: 22240256 [TBL] [Abstract][Full Text] [Related]
10. Elevated expression of miR-155 is associated with the differentiation of CD8+ T cells in patients with HIV-1. Jin C; Cheng L; Lu X; Xie T; Wu H; Wu N Mol Med Rep; 2017 Aug; 16(2):1584-1589. PubMed ID: 28627655 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomic meta-analysis identifies gene expression characteristics in various samples of HIV-infected patients with nonprogressive disease. Zhang LL; Zhang ZN; Wu X; Jiang YJ; Fu YJ; Shang H J Transl Med; 2017 Sep; 15(1):191. PubMed ID: 28899396 [TBL] [Abstract][Full Text] [Related]
12. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles. Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762 [TBL] [Abstract][Full Text] [Related]
13. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children. Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588 [TBL] [Abstract][Full Text] [Related]
14. Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression. Hubert A; Subra C; Jenabian MA; Tremblay Labrecque PF; Tremblay C; Laffont B; Provost P; Routy JP; Gilbert C J Acquir Immune Defic Syndr; 2015 Nov; 70(3):219-27. PubMed ID: 26181817 [TBL] [Abstract][Full Text] [Related]
15. Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART. López M; Soriano V; Peris-Pertusa A; Rallón N; Restrepo C; Benito JM AIDS Res Hum Retroviruses; 2011 Feb; 27(2):157-65. PubMed ID: 20964478 [TBL] [Abstract][Full Text] [Related]
16. Metabolic pathway activation distinguishes transcriptional signatures of CD8+ T cells from HIV-1 elite controllers. Chowdhury FZ; Ouyang Z; Buzon M; Walker BD; Lichterfeld M; Yu XG AIDS; 2018 Nov; 32(18):2669-2677. PubMed ID: 30289807 [TBL] [Abstract][Full Text] [Related]
17. The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study. Meijerink H; Indrati AR; van Crevel R; Joosten I; Koenen H; van der Ven AJ BMC Infect Dis; 2014 Dec; 14():683. PubMed ID: 25495598 [TBL] [Abstract][Full Text] [Related]
18. Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells. Jensen SS; Fomsgaard A; Larsen TK; Tingstedt JL; Gerstoft J; Kronborg G; Pedersen C; Karlsson I PLoS One; 2015; 10(10):e0139573. PubMed ID: 26426913 [TBL] [Abstract][Full Text] [Related]
19. The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers. Ndhlovu ZM; Stampouloglou E; Cesa K; Mavrothalassitis O; Alvino DM; Li JZ; Wilton S; Karel D; Piechocka-Trocha A; Chen H; Pereyra F; Walker BD J Virol; 2015 Nov; 89(21):10735-47. PubMed ID: 26269189 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals. Ndumbi P; Gilbert L; Tsoukas CM PLoS One; 2015; 10(2):e0117039. PubMed ID: 25647167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]